| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |